Rosemarie Mick

faculty photo
Adjunct Associate Professor of Biostatistics in Biostatistics and Epidemiology
Member, Biostatistics Core Facility, Abramson Cancer Center, University of Pennsylvania
Senior Research Investigator, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine
Member, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania
Department: Biostatistics and Epidemiology

Contact information
Department of Biostatistics & Epidemiology
University of Pennsylvania Perelman School of Medicine
609 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215 898 9057
Fax: 215 573 4865
Education:
AA
Onondaga Community College, 1974.
BS (Mathematics)
University of Utah , 1980.
MS (Biostatistics)
University of Utah , 1982.
Permanent link
 

Description of Itmat Expertise

Ms. Mick is interested in the definition of molecular signatures (of genes, proteins or RNA) to sort patients into risk strata. Issues of the development, validation and use of such tools have become central to contemporary clinical cancer research.

Selected Publications

Lin L, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R and Kennedy A: Phase I randomized double-blind placebo controlled single dose safety studies of Bowman Birk inhibitor concentrate. Oncology Letters 7: 1151-1158, 2014.

Vonderheide R, Burg J, Mick R, Trosko J, Huhn R, Li D, Shaik N, Tolcher A and Hamid O: Phase I study of CD40 antibody CP-870,893 in combination with carboplatin and paclitaxel in patients with advanced solid tumors. OncoImmunology 2: 1-10, 2013 [Epub On-line]

Kandalaft L, Powell D, Chiang C, Tanyi J, Kim S, Bosch M, Montone K, Mick R, Levine B, Torigian D, June C, and Coukos G: Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo costimulated T-cells in recurrent ovarian cancer. OncoImmunology 2: 1-9, 2013 [Epub On-line]

Bauml J, Mick R, Zhang Y, Watt C, Vachani A, Aggarwal C and Langer C: Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background. Lung Cancer 81: 347-353, 2013.

Kandalaft L, Chiang C, Tanyi J, Motz G, Balint K, Mick R and Coukos G: A phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. Journal of Translational Medicine 11: 149, 2013.

Fracol M, Xu S, Mick R, Fitzpatrick E, Nisenbaum H, Roses R, Fisher C, Tchou J, Fox K, Zhang P and Czerniecki B: Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS. Annals of Surgical Oncology 20: 3233-3239, 2013.

Bauml J, Mick R, Zhang Y, Watt C, Vachani A, Aggarwal C and Langer C: Determinants of survival in advanced non small cell lung cancer (NSCLC) in the era of targeted therapies. Clinical Lung Cancer 14: 581-589, 2013.

Chiang C, Kandalaft L, Tanyi J, Hagemann A, Motz G, Svoronos N, Smith L, Montone K, Mantia-Smaldone G, Nisenbaum H, TOrigian D, Levine B, Mick R, Kalos M, Czerniecki B, Powell D and Coukos G: A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: From bench to bedside. Clinical Cancer Research 19: 4801-4815, 2013.

Berman A, Turowski J, Mick R, Cengel K, Farnese N, Basel-Brown L, Mesaros C, Blair I, Lawson J, Christofidou-Solomidou M, Lee J and Rengan R: Dietary flaxseed in non-small cell lung cancer patients receiving chemoradiation. Journal of Pulmonary and Respiratory Medicine 3: 154, 2013 Notes: doi:10.4172/2161-105X. 1000154.

Sanzari J, Wan X, Krigsfield G, King G, Miller A, Mick R, Gridley D, Wroe A and Kennedy A: Effects of solar particle event proton radiation on parameters related to ferret emesis. Radiation Research 180: 166-176, 2013.

back to top
Last updated: 04/17/2014
The Trustees of the University of Pennsylvania